Why Doctors Are Now Recommending Psilocybin Therapy for Treatment-Resistant Depression
Depression affects about one in six people throughout their lifetimes, with psilocybin therapy emerging as a groundbreaking approach for those who haven't responded to conventional treatments. Over 300 million people worldwide suffer from this debilitating mental disorder, yet current treatment options fail to help up to 30% of patients. Surprisingly, recent clinical studies show that psychedelic therapy using psilocybin can create lasting improvements in depression symptoms. Patients experienced significant decreases in depression severity from 22.8 at pretreatment to just 7.7 at 12 months after treatment, with 75% response and 58% remission rates a year later. This remarkable effectiveness has led the FDA to grant psilocybin treatment for depression "breakthrough therapy" status. Today, we'll explore why psilocybin for depression is gaining medical recognition, how these treatments work, and what patients are experiencing during their therapeutic journeys. We'...